The pill is made by Novo Nordisk, the same company that makes Ozempic.
Novo Nordisk released data Wednesday showing that patients taking its new medication, a pill known as amycretin, lost up to 13% of their body weight after 12 weeks, with mild to moderate side effects.
The study results released Wednesday by Novo Nordisk were based on a small trial of 124 participants.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early TrialRobert Hart is a senior reporter for Forbes covering science, technology and health with a frequent focus on artificial intelligence, space, weight loss drugs and emerging technologies. He joined Forbes in 2020 and is based in London. Rob has covered everything from the billionaire space race, the health impacts of overturning Roe v.
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »
Novo Nordisk weight-loss drug is effective for kids as young as 6, study showsA drug approved to treat obesity in adults and teens is safe and effective for use in kids as young as 6 when combined with diet and exercise, a small new study…
Read more »